 |
 |
A modified tetracycline antibiotic appears to prevent brain cell loss like that seen in Parkinson's disease, according to findings from a study in mice. The drug, called minocycline, prevented degeneration in dopamine-producing brain cells in mice that were made to have a Parkinson's-like disease. Parkinson's is marked by the destruction of brain cells that produce dopamine, a chemical that is a key regulator of muscle movement. "Chemically modified tetracyclines, like minocycline, may prove effective in preventing and/or altering the progression of Parkinson's disease," conclude researchers led by Steven M. Paul of the Indiana University School of Medicine in Indianapolis. Paul also works for the drugmaker Eli Lilly and Company, which funded the study. Click Here: <A HREF="http://news.excite.com/news/r/011126/17/health-mice"> Antibiotic Treats Parkinson's-Like Damage in Mi…</A> Or: http://news.excite.com/news/r/011126/17/health-mice ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn